Request for Covid-19 Impact Assessment of this Report
The United States Molecular Diagnosis of Clostridium Difficile market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Molecular Diagnosis of Clostridium Difficile market, reaching US$ million by the year 2028. As for the Europe Molecular Diagnosis of Clostridium Difficile landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Molecular Diagnosis of Clostridium Difficile players cover Roche, Thermo Scientific, Cepheid (Danaher), and BD, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnosis of Clostridium Difficile market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Sensitivity Above 90%
Sensitivity Below 90%
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Laboratory
Home Care
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Roche
Thermo Scientific
Cepheid (Danaher)
BD
Meridian
TECHLAB
Luminex
CerTest Biotec
Quidel
Zhejiang Orient Gene Biotech
Beijing Promed Medical Technology
Jiangsu Besthree Biotechnology
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Molecular Diagnosis of Clostridium Difficile Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Molecular Diagnosis of Clostridium Difficile by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Molecular Diagnosis of Clostridium Difficile by Country/Region, 2017, 2022 & 2028
2.2 Molecular Diagnosis of Clostridium Difficile Segment by Type
2.2.1 Sensitivity Above 90%
2.2.2 Sensitivity Below 90%
2.3 Molecular Diagnosis of Clostridium Difficile Sales by Type
2.3.1 Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Type (2017-2022)
2.3.2 Global Molecular Diagnosis of Clostridium Difficile Revenue and Market Share by Type (2017-2022)
2.3.3 Global Molecular Diagnosis of Clostridium Difficile Sale Price by Type (2017-2022)
2.4 Molecular Diagnosis of Clostridium Difficile Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Laboratory
2.4.4 Home Care
2.4.5 Others
2.5 Molecular Diagnosis of Clostridium Difficile Sales by Application
2.5.1 Global Molecular Diagnosis of Clostridium Difficile Sale Market Share by Application (2017-2022)
2.5.2 Global Molecular Diagnosis of Clostridium Difficile Revenue and Market Share by Application (2017-2022)
2.5.3 Global Molecular Diagnosis of Clostridium Difficile Sale Price by Application (2017-2022)
3 Global Molecular Diagnosis of Clostridium Difficile by Company
3.1 Global Molecular Diagnosis of Clostridium Difficile Breakdown Data by Company
3.1.1 Global Molecular Diagnosis of Clostridium Difficile Annual Sales by Company (2020-2022)
3.1.2 Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Company (2020-2022)
3.2 Global Molecular Diagnosis of Clostridium Difficile Annual Revenue by Company (2020-2022)
3.2.1 Global Molecular Diagnosis of Clostridium Difficile Revenue by Company (2020-2022)
3.2.2 Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Company (2020-2022)
3.3 Global Molecular Diagnosis of Clostridium Difficile Sale Price by Company
3.4 Key Manufacturers Molecular Diagnosis of Clostridium Difficile Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Molecular Diagnosis of Clostridium Difficile Product Location Distribution
3.4.2 Players Molecular Diagnosis of Clostridium Difficile Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Molecular Diagnosis of Clostridium Difficile by Geographic Region
4.1 World Historic Molecular Diagnosis of Clostridium Difficile Market Size by Geographic Region (2017-2022)
4.1.1 Global Molecular Diagnosis of Clostridium Difficile Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Molecular Diagnosis of Clostridium Difficile Annual Revenue by Geographic Region
4.2 World Historic Molecular Diagnosis of Clostridium Difficile Market Size by Country/Region (2017-2022)
4.2.1 Global Molecular Diagnosis of Clostridium Difficile Annual Sales by Country/Region (2017-2022)
4.2.2 Global Molecular Diagnosis of Clostridium Difficile Annual Revenue by Country/Region
4.3 Americas Molecular Diagnosis of Clostridium Difficile Sales Growth
4.4 APAC Molecular Diagnosis of Clostridium Difficile Sales Growth
4.5 Europe Molecular Diagnosis of Clostridium Difficile Sales Growth
4.6 Middle East & Africa Molecular Diagnosis of Clostridium Difficile Sales Growth
5 Americas
5.1 Americas Molecular Diagnosis of Clostridium Difficile Sales by Country
5.1.1 Americas Molecular Diagnosis of Clostridium Difficile Sales by Country (2017-2022)
5.1.2 Americas Molecular Diagnosis of Clostridium Difficile Revenue by Country (2017-2022)
5.2 Americas Molecular Diagnosis of Clostridium Difficile Sales by Type
5.3 Americas Molecular Diagnosis of Clostridium Difficile Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnosis of Clostridium Difficile Sales by Region
6.1.1 APAC Molecular Diagnosis of Clostridium Difficile Sales by Region (2017-2022)
6.1.2 APAC Molecular Diagnosis of Clostridium Difficile Revenue by Region (2017-2022)
6.2 APAC Molecular Diagnosis of Clostridium Difficile Sales by Type
6.3 APAC Molecular Diagnosis of Clostridium Difficile Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Molecular Diagnosis of Clostridium Difficile by Country
7.1.1 Europe Molecular Diagnosis of Clostridium Difficile Sales by Country (2017-2022)
7.1.2 Europe Molecular Diagnosis of Clostridium Difficile Revenue by Country (2017-2022)
7.2 Europe Molecular Diagnosis of Clostridium Difficile Sales by Type
7.3 Europe Molecular Diagnosis of Clostridium Difficile Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Molecular Diagnosis of Clostridium Difficile by Country
8.1.1 Middle East & Africa Molecular Diagnosis of Clostridium Difficile Sales by Country (2017-2022)
8.1.2 Middle East & Africa Molecular Diagnosis of Clostridium Difficile Revenue by Country (2017-2022)
8.2 Middle East & Africa Molecular Diagnosis of Clostridium Difficile Sales by Type
8.3 Middle East & Africa Molecular Diagnosis of Clostridium Difficile Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Molecular Diagnosis of Clostridium Difficile
10.3 Manufacturing Process Analysis of Molecular Diagnosis of Clostridium Difficile
10.4 Industry Chain Structure of Molecular Diagnosis of Clostridium Difficile
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Molecular Diagnosis of Clostridium Difficile Distributors
11.3 Molecular Diagnosis of Clostridium Difficile Customer
12 World Forecast Review for Molecular Diagnosis of Clostridium Difficile by Geographic Region
12.1 Global Molecular Diagnosis of Clostridium Difficile Market Size Forecast by Region
12.1.1 Global Molecular Diagnosis of Clostridium Difficile Forecast by Region (2023-2028)
12.1.2 Global Molecular Diagnosis of Clostridium Difficile Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Molecular Diagnosis of Clostridium Difficile Forecast by Type
12.7 Global Molecular Diagnosis of Clostridium Difficile Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Molecular Diagnosis of Clostridium Difficile Product Offered
13.1.3 Roche Molecular Diagnosis of Clostridium Difficile Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Thermo Scientific
13.2.1 Thermo Scientific Company Information
13.2.2 Thermo Scientific Molecular Diagnosis of Clostridium Difficile Product Offered
13.2.3 Thermo Scientific Molecular Diagnosis of Clostridium Difficile Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Thermo Scientific Main Business Overview
13.2.5 Thermo Scientific Latest Developments
13.3 Cepheid (Danaher)
13.3.1 Cepheid (Danaher) Company Information
13.3.2 Cepheid (Danaher) Molecular Diagnosis of Clostridium Difficile Product Offered
13.3.3 Cepheid (Danaher) Molecular Diagnosis of Clostridium Difficile Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Cepheid (Danaher) Main Business Overview
13.3.5 Cepheid (Danaher) Latest Developments
13.4 BD
13.4.1 BD Company Information
13.4.2 BD Molecular Diagnosis of Clostridium Difficile Product Offered
13.4.3 BD Molecular Diagnosis of Clostridium Difficile Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 BD Main Business Overview
13.4.5 BD Latest Developments
13.5 Meridian
13.5.1 Meridian Company Information
13.5.2 Meridian Molecular Diagnosis of Clostridium Difficile Product Offered
13.5.3 Meridian Molecular Diagnosis of Clostridium Difficile Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Meridian Main Business Overview
13.5.5 Meridian Latest Developments
13.6 TECHLAB
13.6.1 TECHLAB Company Information
13.6.2 TECHLAB Molecular Diagnosis of Clostridium Difficile Product Offered
13.6.3 TECHLAB Molecular Diagnosis of Clostridium Difficile Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 TECHLAB Main Business Overview
13.6.5 TECHLAB Latest Developments
13.7 Luminex
13.7.1 Luminex Company Information
13.7.2 Luminex Molecular Diagnosis of Clostridium Difficile Product Offered
13.7.3 Luminex Molecular Diagnosis of Clostridium Difficile Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Luminex Main Business Overview
13.7.5 Luminex Latest Developments
13.8 CerTest Biotec
13.8.1 CerTest Biotec Company Information
13.8.2 CerTest Biotec Molecular Diagnosis of Clostridium Difficile Product Offered
13.8.3 CerTest Biotec Molecular Diagnosis of Clostridium Difficile Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 CerTest Biotec Main Business Overview
13.8.5 CerTest Biotec Latest Developments
13.9 Quidel
13.9.1 Quidel Company Information
13.9.2 Quidel Molecular Diagnosis of Clostridium Difficile Product Offered
13.9.3 Quidel Molecular Diagnosis of Clostridium Difficile Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Quidel Main Business Overview
13.9.5 Quidel Latest Developments
13.10 Zhejiang Orient Gene Biotech
13.10.1 Zhejiang Orient Gene Biotech Company Information
13.10.2 Zhejiang Orient Gene Biotech Molecular Diagnosis of Clostridium Difficile Product Offered
13.10.3 Zhejiang Orient Gene Biotech Molecular Diagnosis of Clostridium Difficile Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Zhejiang Orient Gene Biotech Main Business Overview
13.10.5 Zhejiang Orient Gene Biotech Latest Developments
13.11 Beijing Promed Medical Technology
13.11.1 Beijing Promed Medical Technology Company Information
13.11.2 Beijing Promed Medical Technology Molecular Diagnosis of Clostridium Difficile Product Offered
13.11.3 Beijing Promed Medical Technology Molecular Diagnosis of Clostridium Difficile Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Beijing Promed Medical Technology Main Business Overview
13.11.5 Beijing Promed Medical Technology Latest Developments
13.12 Jiangsu Besthree Biotechnology
13.12.1 Jiangsu Besthree Biotechnology Company Information
13.12.2 Jiangsu Besthree Biotechnology Molecular Diagnosis of Clostridium Difficile Product Offered
13.12.3 Jiangsu Besthree Biotechnology Molecular Diagnosis of Clostridium Difficile Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Jiangsu Besthree Biotechnology Main Business Overview
13.12.5 Jiangsu Besthree Biotechnology Latest Developments
14 Research Findings and Conclusion
Table 1. Molecular Diagnosis of Clostridium Difficile Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Molecular Diagnosis of Clostridium Difficile Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Sensitivity Above 90%
Table 4. Major Players of Sensitivity Below 90%
Table 5. Global Molecular Diagnosis of Clostridium Difficile Sales by Type (2017-2022) & (K Units)
Table 6. Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Type (2017-2022)
Table 7. Global Molecular Diagnosis of Clostridium Difficile Revenue by Type (2017-2022) & ($ million)
Table 8. Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Type (2017-2022)
Table 9. Global Molecular Diagnosis of Clostridium Difficile Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Molecular Diagnosis of Clostridium Difficile Sales by Application (2017-2022) & (K Units)
Table 11. Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Application (2017-2022)
Table 12. Global Molecular Diagnosis of Clostridium Difficile Revenue by Application (2017-2022)
Table 13. Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Application (2017-2022)
Table 14. Global Molecular Diagnosis of Clostridium Difficile Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Molecular Diagnosis of Clostridium Difficile Sales by Company (2020-2022) & (K Units)
Table 16. Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Company (2020-2022)
Table 17. Global Molecular Diagnosis of Clostridium Difficile Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Company (2020-2022)
Table 19. Global Molecular Diagnosis of Clostridium Difficile Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Molecular Diagnosis of Clostridium Difficile Producing Area Distribution and Sales Area
Table 21. Players Molecular Diagnosis of Clostridium Difficile Products Offered
Table 22. Molecular Diagnosis of Clostridium Difficile Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Molecular Diagnosis of Clostridium Difficile Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Molecular Diagnosis of Clostridium Difficile Sales Market Share Geographic Region (2017-2022)
Table 27. Global Molecular Diagnosis of Clostridium Difficile Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Molecular Diagnosis of Clostridium Difficile Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Country/Region (2017-2022)
Table 31. Global Molecular Diagnosis of Clostridium Difficile Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Molecular Diagnosis of Clostridium Difficile Sales by Country (2017-2022) & (K Units)
Table 34. Americas Molecular Diagnosis of Clostridium Difficile Sales Market Share by Country (2017-2022)
Table 35. Americas Molecular Diagnosis of Clostridium Difficile Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Country (2017-2022)
Table 37. Americas Molecular Diagnosis of Clostridium Difficile Sales by Type (2017-2022) & (K Units)
Table 38. Americas Molecular Diagnosis of Clostridium Difficile Sales Market Share by Type (2017-2022)
Table 39. Americas Molecular Diagnosis of Clostridium Difficile Sales by Application (2017-2022) & (K Units)
Table 40. Americas Molecular Diagnosis of Clostridium Difficile Sales Market Share by Application (2017-2022)
Table 41. APAC Molecular Diagnosis of Clostridium Difficile Sales by Region (2017-2022) & (K Units)
Table 42. APAC Molecular Diagnosis of Clostridium Difficile Sales Market Share by Region (2017-2022)
Table 43. APAC Molecular Diagnosis of Clostridium Difficile Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Region (2017-2022)
Table 45. APAC Molecular Diagnosis of Clostridium Difficile Sales by Type (2017-2022) & (K Units)
Table 46. APAC Molecular Diagnosis of Clostridium Difficile Sales Market Share by Type (2017-2022)
Table 47. APAC Molecular Diagnosis of Clostridium Difficile Sales by Application (2017-2022) & (K Units)
Table 48. APAC Molecular Diagnosis of Clostridium Difficile Sales Market Share by Application (2017-2022)
Table 49. Europe Molecular Diagnosis of Clostridium Difficile Sales by Country (2017-2022) & (K Units)
Table 50. Europe Molecular Diagnosis of Clostridium Difficile Sales Market Share by Country (2017-2022)
Table 51. Europe Molecular Diagnosis of Clostridium Difficile Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Country (2017-2022)
Table 53. Europe Molecular Diagnosis of Clostridium Difficile Sales by Type (2017-2022) & (K Units)
Table 54. Europe Molecular Diagnosis of Clostridium Difficile Sales Market Share by Type (2017-2022)
Table 55. Europe Molecular Diagnosis of Clostridium Difficile Sales by Application (2017-2022) & (K Units)
Table 56. Europe Molecular Diagnosis of Clostridium Difficile Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Molecular Diagnosis of Clostridium Difficile Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Molecular Diagnosis of Clostridium Difficile Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Molecular Diagnosis of Clostridium Difficile Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Molecular Diagnosis of Clostridium Difficile Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Molecular Diagnosis of Clostridium Difficile Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Molecular Diagnosis of Clostridium Difficile Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Molecular Diagnosis of Clostridium Difficile Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Molecular Diagnosis of Clostridium Difficile
Table 66. Key Market Challenges & Risks of Molecular Diagnosis of Clostridium Difficile
Table 67. Key Industry Trends of Molecular Diagnosis of Clostridium Difficile
Table 68. Molecular Diagnosis of Clostridium Difficile Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Molecular Diagnosis of Clostridium Difficile Distributors List
Table 71. Molecular Diagnosis of Clostridium Difficile Customer List
Table 72. Global Molecular Diagnosis of Clostridium Difficile Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Molecular Diagnosis of Clostridium Difficile Sales Market Forecast by Region
Table 74. Global Molecular Diagnosis of Clostridium Difficile Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Molecular Diagnosis of Clostridium Difficile Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Molecular Diagnosis of Clostridium Difficile Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Molecular Diagnosis of Clostridium Difficile Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Molecular Diagnosis of Clostridium Difficile Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Molecular Diagnosis of Clostridium Difficile Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Molecular Diagnosis of Clostridium Difficile Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Molecular Diagnosis of Clostridium Difficile Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Molecular Diagnosis of Clostridium Difficile Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Molecular Diagnosis of Clostridium Difficile Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Molecular Diagnosis of Clostridium Difficile Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Molecular Diagnosis of Clostridium Difficile Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Molecular Diagnosis of Clostridium Difficile Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Molecular Diagnosis of Clostridium Difficile Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Molecular Diagnosis of Clostridium Difficile Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share Forecast by Application (2023-2028)
Table 92. Roche Basic Information, Molecular Diagnosis of Clostridium Difficile Manufacturing Base, Sales Area and Its Competitors
Table 93. Roche Molecular Diagnosis of Clostridium Difficile Product Offered
Table 94. Roche Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Roche Main Business
Table 96. Roche Latest Developments
Table 97. Thermo Scientific Basic Information, Molecular Diagnosis of Clostridium Difficile Manufacturing Base, Sales Area and Its Competitors
Table 98. Thermo Scientific Molecular Diagnosis of Clostridium Difficile Product Offered
Table 99. Thermo Scientific Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Thermo Scientific Main Business
Table 101. Thermo Scientific Latest Developments
Table 102. Cepheid (Danaher) Basic Information, Molecular Diagnosis of Clostridium Difficile Manufacturing Base, Sales Area and Its Competitors
Table 103. Cepheid (Danaher) Molecular Diagnosis of Clostridium Difficile Product Offered
Table 104. Cepheid (Danaher) Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Cepheid (Danaher) Main Business
Table 106. Cepheid (Danaher) Latest Developments
Table 107. BD Basic Information, Molecular Diagnosis of Clostridium Difficile Manufacturing Base, Sales Area and Its Competitors
Table 108. BD Molecular Diagnosis of Clostridium Difficile Product Offered
Table 109. BD Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. BD Main Business
Table 111. BD Latest Developments
Table 112. Meridian Basic Information, Molecular Diagnosis of Clostridium Difficile Manufacturing Base, Sales Area and Its Competitors
Table 113. Meridian Molecular Diagnosis of Clostridium Difficile Product Offered
Table 114. Meridian Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Meridian Main Business
Table 116. Meridian Latest Developments
Table 117. TECHLAB Basic Information, Molecular Diagnosis of Clostridium Difficile Manufacturing Base, Sales Area and Its Competitors
Table 118. TECHLAB Molecular Diagnosis of Clostridium Difficile Product Offered
Table 119. TECHLAB Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. TECHLAB Main Business
Table 121. TECHLAB Latest Developments
Table 122. Luminex Basic Information, Molecular Diagnosis of Clostridium Difficile Manufacturing Base, Sales Area and Its Competitors
Table 123. Luminex Molecular Diagnosis of Clostridium Difficile Product Offered
Table 124. Luminex Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Luminex Main Business
Table 126. Luminex Latest Developments
Table 127. CerTest Biotec Basic Information, Molecular Diagnosis of Clostridium Difficile Manufacturing Base, Sales Area and Its Competitors
Table 128. CerTest Biotec Molecular Diagnosis of Clostridium Difficile Product Offered
Table 129. CerTest Biotec Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. CerTest Biotec Main Business
Table 131. CerTest Biotec Latest Developments
Table 132. Quidel Basic Information, Molecular Diagnosis of Clostridium Difficile Manufacturing Base, Sales Area and Its Competitors
Table 133. Quidel Molecular Diagnosis of Clostridium Difficile Product Offered
Table 134. Quidel Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Quidel Main Business
Table 136. Quidel Latest Developments
Table 137. Zhejiang Orient Gene Biotech Basic Information, Molecular Diagnosis of Clostridium Difficile Manufacturing Base, Sales Area and Its Competitors
Table 138. Zhejiang Orient Gene Biotech Molecular Diagnosis of Clostridium Difficile Product Offered
Table 139. Zhejiang Orient Gene Biotech Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Zhejiang Orient Gene Biotech Main Business
Table 141. Zhejiang Orient Gene Biotech Latest Developments
Table 142. Beijing Promed Medical Technology Basic Information, Molecular Diagnosis of Clostridium Difficile Manufacturing Base, Sales Area and Its Competitors
Table 143. Beijing Promed Medical Technology Molecular Diagnosis of Clostridium Difficile Product Offered
Table 144. Beijing Promed Medical Technology Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Beijing Promed Medical Technology Main Business
Table 146. Beijing Promed Medical Technology Latest Developments
Table 147. Jiangsu Besthree Biotechnology Basic Information, Molecular Diagnosis of Clostridium Difficile Manufacturing Base, Sales Area and Its Competitors
Table 148. Jiangsu Besthree Biotechnology Molecular Diagnosis of Clostridium Difficile Product Offered
Table 149. Jiangsu Besthree Biotechnology Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Jiangsu Besthree Biotechnology Main Business
Table 151. Jiangsu Besthree Biotechnology Latest Developments
List of Figures
Figure 1. Picture of Molecular Diagnosis of Clostridium Difficile
Figure 2. Molecular Diagnosis of Clostridium Difficile Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Molecular Diagnosis of Clostridium Difficile Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Molecular Diagnosis of Clostridium Difficile Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Molecular Diagnosis of Clostridium Difficile Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Sensitivity Above 90%
Figure 10. Product Picture of Sensitivity Below 90%
Figure 11. Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Type in 2021
Figure 12. Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Type (2017-2022)
Figure 13. Molecular Diagnosis of Clostridium Difficile Consumed in Hospital
Figure 14. Global Molecular Diagnosis of Clostridium Difficile Market: Hospital (2017-2022) & (K Units)
Figure 15. Molecular Diagnosis of Clostridium Difficile Consumed in Clinic
Figure 16. Global Molecular Diagnosis of Clostridium Difficile Market: Clinic (2017-2022) & (K Units)
Figure 17. Molecular Diagnosis of Clostridium Difficile Consumed in Laboratory
Figure 18. Global Molecular Diagnosis of Clostridium Difficile Market: Laboratory (2017-2022) & (K Units)
Figure 19. Molecular Diagnosis of Clostridium Difficile Consumed in Home Care
Figure 20. Global Molecular Diagnosis of Clostridium Difficile Market: Home Care (2017-2022) & (K Units)
Figure 21. Molecular Diagnosis of Clostridium Difficile Consumed in Others
Figure 22. Global Molecular Diagnosis of Clostridium Difficile Market: Others (2017-2022) & (K Units)
Figure 23. Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Application (2017-2022)
Figure 24. Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Application in 2021
Figure 25. Molecular Diagnosis of Clostridium Difficile Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Company in 2021
Figure 27. Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Geographic Region in 2021
Figure 29. Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Region (2017-2022)
Figure 30. Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Country/Region in 2021
Figure 31. Americas Molecular Diagnosis of Clostridium Difficile Sales 2017-2022 (K Units)
Figure 32. Americas Molecular Diagnosis of Clostridium Difficile Revenue 2017-2022 ($ Millions)
Figure 33. APAC Molecular Diagnosis of Clostridium Difficile Sales 2017-2022 (K Units)
Figure 34. APAC Molecular Diagnosis of Clostridium Difficile Revenue 2017-2022 ($ Millions)
Figure 35. Europe Molecular Diagnosis of Clostridium Difficile Sales 2017-2022 (K Units)
Figure 36. Europe Molecular Diagnosis of Clostridium Difficile Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Molecular Diagnosis of Clostridium Difficile Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Molecular Diagnosis of Clostridium Difficile Revenue 2017-2022 ($ Millions)
Figure 39. Americas Molecular Diagnosis of Clostridium Difficile Sales Market Share by Country in 2021
Figure 40. Americas Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Country in 2021
Figure 41. United States Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Molecular Diagnosis of Clostridium Difficile Sales Market Share by Region in 2021
Figure 46. APAC Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Regions in 2021
Figure 47. China Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Molecular Diagnosis of Clostridium Difficile Sales Market Share by Country in 2021
Figure 54. Europe Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Country in 2021
Figure 55. Germany Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Molecular Diagnosis of Clostridium Difficile Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Country in 2021
Figure 62. Egypt Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Molecular Diagnosis of Clostridium Difficile Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Molecular Diagnosis of Clostridium Difficile in 2021
Figure 68. Manufacturing Process Analysis of Molecular Diagnosis of Clostridium Difficile
Figure 69. Industry Chain Structure of Molecular Diagnosis of Clostridium Difficile
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...